BREAKING: FDA Data Reanalysis Sent to HHS Finds Moderna’s mRNA Flu Shot Approval Should Be Immediately Withdrawn

We directly reanalyzed the FDA’s own data used to approve mFLUSIVA and found an extreme risk-benefit profile that is impossible to justify.